{"id":23077,"date":"2023-07-17T13:00:34","date_gmt":"2023-07-17T20:00:34","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23077"},"modified":"2025-05-12T09:14:55","modified_gmt":"2025-05-12T16:14:55","slug":"exploring-ivig-therapy-for-dermatomyositis","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/","title":{"rendered":"Explorando la terapia con IgIV para la dermatomiositis"},"content":{"rendered":"<p>La dermatomiositis es una enfermedad autoinmune poco com\u00fan que puede afectar tanto a ni\u00f1os como a adultos. A\u00fan no existe cura para la dermatomiositis. Sin embargo, puede evitar sus consecuencias debilitantes mediante tratamiento. Una terapia eficaz para la dermatomiositis es la inmunoglobulina intravenosa (IVIG).<\/p>\n\n\n\n<p>Si acabas de o\u00edr hablar de <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/what-to-expect-during-your-ivig-infusion-treatment\/\">Tratamiento con IgIV<\/a> Para la dermatomiositis, esta mirada en profundidad a la terapia es el mejor lugar para comenzar.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#What_is_Dermatomyositis\" >\u00bfQu\u00e9 es la dermatomiositis?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Symptoms\" >S\u00edntomas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Causes\" >Causas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Diagnosis\" >Diagn\u00f3stico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Treatments\" >Tratos<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#IVIG_Treatment_for_Dermatomyositis\" >Tratamiento con IgIV para la dermatomiositis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Is_IVIG_Treatment_Effective_for_Dermatomyositis\" >\u00bfEs eficaz el tratamiento con IgIV para la dermatomiositis?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#16-Week_Phase\" >Fase de 16 semanas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#24-Week_Phase\" >Fase de 24 semanas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Reported_Adverse_Effects\" >Efectos adversos notificados<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Conclusions\" >Conclusiones<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#IVIG_Procedure\" >Procedimiento de IgIV<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#What_to_Expect\" >Qu\u00e9 esperar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Are_There_Any_Side_Effects\" >\u00bfExisten efectos secundarios?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#The_Cost_of_IVIG_Treatment_for_Dermatomyositis\" >El costo del tratamiento con IgIV para la dermatomiositis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Financial_Assistance_for_IVIG\" >Asistencia financiera para IgIV<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#Receive_IVIG_Therapy_for_Dermatomyositis_from_AmeriPharma%C2%AE_Specialty_Pharmacy\" >Reciba terapia con IgIV para la dermatomiositis en la farmacia especializada AmeriPharma\u00ae<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-dermatomyositis\"><span class=\"ez-toc-section\" id=\"What_is_Dermatomyositis\"><\/span>\u00bfQu\u00e9 es la dermatomiositis?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Antes de explorar el tratamiento, debes comprender la enfermedad. <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/dermatomyositis\/symptoms-causes\/syc-20353188\">Dermatomiositis<\/a> Es una enfermedad inflamatoria poco com\u00fan que causa inflamaci\u00f3n muscular. Se diferencia de otras enfermedades musculares en que tambi\u00e9n puede causar s\u00edntomas cut\u00e1neos.<\/p>\n\n\n\n<p>Tanto adultos como ni\u00f1os pueden padecer dermatomiositis. Sin embargo, esta afecci\u00f3n afecta principalmente a personas de entre 50 y 70 a\u00f1os y es m\u00e1s com\u00fan en mujeres.<\/p>\n\n\n\n<p>Algunas personas con dermatomiositis tambi\u00e9n pueden sufrir trastornos del tejido conectivo como lupus o artritis reumatoide.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-symptoms\"><span class=\"ez-toc-section\" id=\"Symptoms\"><\/span>S\u00edntomas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los s\u00edntomas de la dermatomiositis que la IgIV intenta mejorar incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fiebre<\/li>\n\n\n\n<li>Fatiga<\/li>\n\n\n\n<li>Cambios de voz<\/li>\n\n\n\n<li>Articulaciones r\u00edgidas y dolorosas<\/li>\n\n\n\n<li>Dificultades para tragar<\/li>\n\n\n\n<li>P\u00e9rdida de peso involuntaria<\/li>\n\n\n\n<li>Debilidad y dolor muscular<\/li>\n\n\n\n<li>Erupciones rojas o moradas en la piel<\/li>\n\n\n\n<li>\u00c1reas hinchadas alrededor de las u\u00f1as.<\/li>\n\n\n\n<li>Piel seca y escamosa que provoca la ca\u00edda del cabello.<\/li>\n\n\n\n<li>Bultos subcut\u00e1neos duros de dep\u00f3sitos de calcio<\/li>\n\n\n\n<li>Problemas pulmonares, incluyendo tos y dificultades respiratorias.<\/li>\n<\/ul>\n\n\n\n<p>Estos s\u00edntomas se producen debido a la inflamaci\u00f3n de los vasos sangu\u00edneos que llegan a la piel y los m\u00fasculos.<\/p>\n\n\n\n<p>En la mayor\u00eda de los casos, el primer signo es la aparici\u00f3n de una erupci\u00f3n morada seguida de dolores musculares. Sin embargo, existe un subtipo de esta enfermedad que no incluye debilidad muscular y se denomina... <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-amyopathic-dermatomyositis-adm\/\">dermatomiositis amiop\u00e1tica<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-causes\"><span class=\"ez-toc-section\" id=\"Causes\"><\/span>Causas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Si bien terapias como la inmunoglobulina intravenosa (IVIG) pueden ayudar con la dermatomiositis, a\u00fan se desconoce la causa exacta de la enfermedad. Sin embargo, la dermatomiositis presenta caracter\u00edsticas similares a las de las enfermedades autoinmunes.<\/p>\n\n\n\n<p>Las enfermedades autoinmunes se producen cuando el sistema inmunitario del cuerpo ataca al propio organismo. Los estudios demuestran que las personas con un sistema inmunitario comprometido tambi\u00e9n son vulnerables a la dermatomiositis, ya que... <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4495251\/\">15%-30%<\/a> de los afectados tienen c\u00e1ncer o infecciones.<\/p>\n\n\n\n<p>Otras posibles causas de dermatomiositis, para las que se utiliza el tratamiento con IgIV, incluyen la exposici\u00f3n a desencadenantes y genes anormales.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-diagnosis\"><span class=\"ez-toc-section\" id=\"Diagnosis\"><\/span>Diagn\u00f3stico<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La dermatomiositis es una enfermedad muscular bastante f\u00e1cil de diagnosticar debido a la aparici\u00f3n de erupciones cut\u00e1neas. El proceso comienza con un m\u00e9dico que le pregunta sobre sus s\u00edntomas, le realiza un examen f\u00edsico y revisa su historial m\u00e9dico.<\/p>\n\n\n\n<p>Antes de prescribir IgIV para la dermatomiositis, el m\u00e9dico tambi\u00e9n realizar\u00e1 las siguientes pruebas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>An\u00e1lisis de sangre para buscar enzimas musculares y prote\u00ednas anormales, incluidos autoanticuerpos.<\/li>\n\n\n\n<li>Electromiograma (EMG) para registrar impulsos anormales en los m\u00fasculos<\/li>\n\n\n\n<li>Resonancias magn\u00e9ticas para buscar inflamaci\u00f3n y m\u00fasculos anormales<\/li>\n\n\n\n<li>Biopsias de piel y m\u00fasculos para buscar cambios inducidos por la dermatomiositis en la piel y los tejidos musculares.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-treatments\"><span class=\"ez-toc-section\" id=\"Treatments\"><\/span>Tratos<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La dermatomiositis no tiene cura, pero sus s\u00edntomas se pueden controlar con tratamiento. La terapia con IgIV para la dermatomiositis no es la \u00fanica opci\u00f3n.<\/p>\n\n\n\n<p>Dependiendo de sus s\u00edntomas, edad y salud general, el m\u00e9dico tambi\u00e9n podr\u00eda recetarle:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fisioterapia para fortalecer tus m\u00fasculos<\/li>\n\n\n\n<li>Tratamientos para la piel y antihistam\u00ednicos para las erupciones cut\u00e1neas<\/li>\n\n\n\n<li>Medicamentos antiinflamatorios como corticosteroides para aliviar la inflamaci\u00f3n.<\/li>\n\n\n\n<li>Cirug\u00eda para eliminar los dep\u00f3sitos de calcio debajo de la piel.<\/li>\n\n\n\n<li>IgIV para modular su sistema inmunol\u00f3gico<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-treatment-for-dermatomyositis\"><span class=\"ez-toc-section\" id=\"IVIG_Treatment_for_Dermatomyositis\"><\/span>Tratamiento con IgIV para la dermatomiositis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-1024x683.jpg\" alt=\"IV drip\" class=\"wp-image-23253\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-1024x683.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-768x512.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-1536x1024.jpg 1536w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-370x247.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-960x640.jpg 960w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1-1280x853.jpg 1280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-treatment-for-dermatomyositis-1.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p>Si tiene dermatomiositis, su cuerpo crea anticuerpos que atacan la piel y los m\u00fasculos. Su cuerpo debe bloquear estos anticuerpos, y eso es lo que hace la IgIV.<\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/immune-globulin-ig\/\">Inmunoglobulina intravenosa (IVIG)<\/a> Es una forma de terapia de infusi\u00f3n que incluye plasma agrupado que contiene anticuerpos recolectados de cientos de donantes sanos.<\/p>\n\n\n\n<p>Cuando las personas con dermatomiositis reciben infusiones de IgIV, estos anticuerpos entran en sus cuerpos. Act\u00faan sobre los autoanticuerpos que da\u00f1an la piel y los m\u00fasculos. Este mecanismo de acci\u00f3n modula el sistema inmunitario y reduce los s\u00edntomas.<\/p>\n\n\n\n<p>Debido a su alto costo, los m\u00e9dicos suelen reservar la IgIV para personas resistentes a otros tratamientos. Sin embargo, la IgIV es un tratamiento muy eficaz. Algunos m\u00e9dicos incluso la recomiendan como terapia de primera l\u00ednea.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-is-ivig-treatment-effective-for-dermatomyositis\"><span class=\"ez-toc-section\" id=\"Is_IVIG_Treatment_Effective_for_Dermatomyositis\"><\/span>\u00bfEs eficaz el tratamiento con IgIV para la dermatomiositis?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36198179\/\">Estudios<\/a> Confirmar la eficacia de la terapia con IgIV para la dermatomiositis. La IgIV tambi\u00e9n ha demostrado su eficacia en un ensayo cl\u00ednico aleatorizado de fase III fundamental.<\/p>\n\n\n\n<p>Los estudios no han evaluado las opciones terap\u00e9uticas para la dermatomiositis, incluyendo corticosteroides y otros inmunosupresores en ensayos de fase III. Por lo tanto, los resultados positivos del ensayo con IgIV son dignos de menci\u00f3n.<\/p>\n\n\n\n<p>Este ensayo cl\u00ednico cont\u00f3 con 95 participantes diagnosticados con dermatomiositis. Tres cuartas partes eran mujeres y m\u00e1s de 90% eran cauc\u00e1sicos. Su edad media era de 53 a\u00f1os.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-16-week-phase\"><span class=\"ez-toc-section\" id=\"16-Week_Phase\"><\/span>Fase de 16 semanas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los cient\u00edficos asignaron aleatoriamente a los participantes a dos grupos durante la primera fase doble ciego de 16 semanas. Un grupo recibi\u00f3 inmunoglobulina intravenosa (IVIG) para la dermatomiositis (Octagam 10%). El otro grupo recibi\u00f3 un placebo.<\/p>\n\n\n\n<p>Los investigadores definieron el criterio de valoraci\u00f3n principal en la semana 16 como una puntuaci\u00f3n de mejora total (TIS) de al menos 20 o ning\u00fan deterioro confirmado hasta esa fecha.<\/p>\n\n\n\n<p>Al final de las primeras 16 semanas, 79% de los participantes que recibieron IgIV y 44% de los que recibieron un placebo con al menos un TIS de 20 continuaron a la siguiente fase.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-24-week-phase\"><span class=\"ez-toc-section\" id=\"24-Week_Phase\"><\/span>Fase de 24 semanas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La segunda fase del ensayo dur\u00f3 otras 24 semanas.<\/p>\n\n\n\n<p>Todos los participantes recibieron infusiones de 2 g\/kg de IgIV para la dermatomiositis durante este per\u00edodo abierto. En la semana 28, los participantes estables recibieron una dosis menor de 1 g\/kg de IgIV para la dermatomiositis durante el resto del ensayo.<\/p>\n\n\n\n<p>Los criterios de valoraci\u00f3n secundarios en la semana 40 se definieron como mejoras moderadas a considerables con un TIS de al menos 40 y 60 puntos, respectivamente.<\/p>\n\n\n\n<p>Al final del ensayo, los investigadores observaron una tasa de respuesta de 71,11 TP448T en el grupo de IgIV y de 69,61 TP448T en el grupo placebo, que posteriormente cambi\u00f3 a IgIV. Estas tasas de respuesta son altamente significativas desde el punto de vista estad\u00edstico.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-reported-adverse-effects\"><span class=\"ez-toc-section\" id=\"Reported_Adverse_Effects\"><\/span>Efectos adversos notificados<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Durante el primer per\u00edodo de 16 semanas, dos tercios de los pacientes informaron efectos secundarios de corta duraci\u00f3n, incluidos dolores de cabeza leves, n\u00e1useas y pirexia, despu\u00e9s de recibir IgIV para la dermatomiositis.<\/p>\n\n\n\n<p>Se presentaron nueve efectos adversos graves, incluidos eventos tromboemb\u00f3licos. Cabe mencionar que quienes recibieron placebo y a\u00fan no hab\u00edan recibido IgIV tambi\u00e9n experimentaron cuatro eventos adversos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-conclusions\"><span class=\"ez-toc-section\" id=\"Conclusions\"><\/span>Conclusiones<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los resultados de este estudio demuestran la eficacia, seguridad y tolerabilidad del tratamiento con IgIV para la dermatomiositis. El porcentaje de mejor\u00eda en los participantes que recibieron IgIV fue mucho m\u00e1s significativo que en los que recibieron placebo.<\/p>\n\n\n\n<p>Este estudio fue el primer ensayo a gran escala controlado con placebo de IgIV para la dermatomiositis y muestra claramente la eficacia de este tratamiento para los afectados.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-procedure\"><span class=\"ez-toc-section\" id=\"IVIG_Procedure\"><\/span>Procedimiento de IgIV<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-1024x683.jpg\" alt=\"A nurse holding a patient\u2019s hand\" class=\"wp-image-23254\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-1024x683.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-768x512.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-1536x1024.jpg 1536w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-370x247.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-960x640.jpg 960w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1-1280x853.jpg 1280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-dermatomyositis-nurse-patient-1.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p>Puedes recibir IgIV <a href=\"https:\/\/ameripharmaspecialty.com\/es\/home-infusion\/\">infusiones caseras<\/a> o recibir tratamiento en un hospital o cl\u00ednica ambulatoria. Enfermeras de infusi\u00f3n certificadas le insertar\u00e1n una aguja en una vena del brazo o le administrar\u00e1n el medicamento por v\u00eda subcut\u00e1nea si as\u00ed lo desea. La soluci\u00f3n de infusi\u00f3n tarda aproximadamente 3 horas en penetrar completamente en su cuerpo.<\/p>\n\n\n\n<p>El proceso en s\u00ed no es doloroso. Sin embargo, podr\u00eda sentir dolor y molestias mientras la enfermera inserta la aguja.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-to-expect\"><span class=\"ez-toc-section\" id=\"What_to_Expect\"><\/span>Qu\u00e9 esperar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Tras recibir IgIV para la dermatomiositis, no notar\u00e1 los efectos inmediatamente. Debe tener paciencia y dejar que los anticuerpos act\u00faen. Pueden pasar varios d\u00edas o semanas antes de que note alguna diferencia.<\/p>\n\n\n\n<p>Sin embargo, la IgIV es un tratamiento de eficacia comprobada para la dermatomiositis. Con el tiempo, notar\u00e1 que las erupciones cut\u00e1neas desaparecen y que sus m\u00fasculos se relajan. Tenga paciencia con el tratamiento y mantenga una actitud positiva.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-are-there-any-side-effects\"><span class=\"ez-toc-section\" id=\"Are_There_Any_Side_Effects\"><\/span>\u00bfExisten efectos secundarios?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La IgIV tiene efectos secundarios poco frecuentes que pueden ser inmediatos o a largo plazo. Los s\u00edntomas que la mayor\u00eda de las personas experimentan incluyen s\u00edntomas gripales, dolor de cabeza leve, fiebre, dolor articular y dolor en el lugar de la inyecci\u00f3n intravenosa.<\/p>\n\n\n\n<p>Menos del 1% de los que reciben IgIV para la dermatomiositis podr\u00edan experimentar los efectos <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-long-term-side-effects\/\">efectos secundarios a largo plazo de la inmunoglobulina intravenosa<\/a> tratamientos, incluyendo insuficiencia renal, eventos tromb\u00f3ticos y trastornos neurol\u00f3gicos.<\/p>\n\n\n\n<p>En algunos casos, los receptores pueden tener una reacci\u00f3n a la infusi\u00f3n y experimentar urticaria y dificultad para respirar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-the-cost-of-ivig-treatment-for-dermatomyositis\"><span class=\"ez-toc-section\" id=\"The_Cost_of_IVIG_Treatment_for_Dermatomyositis\"><\/span>El costo del tratamiento con IgIV para la dermatomiositis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los precios de la terapia con IgIV oscilan entre $100 y $350 por gramo. Este costo puede variar seg\u00fan la edad, el peso, la dosis requerida, la duraci\u00f3n del tratamiento y el m\u00e9todo de inyecci\u00f3n preferido.<\/p>\n\n\n\n<p>El <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig-brand-reviews\/\">marca de la IgIV<\/a> La soluci\u00f3n tambi\u00e9n afecta al precio final. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/octagam\/\">Octagam<\/a> 10% es la marca de IgIV que los m\u00e9dicos suelen recetar para la dermatomiositis. Octagam 10% cuesta $385 por 20 ml.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-financial-assistance-for-ivig\"><span class=\"ez-toc-section\" id=\"Financial_Assistance_for_IVIG\"><\/span>Asistencia financiera para IgIV<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Es innegable que la terapia con IgIV es costosa, especialmente si se necesitan m\u00faltiples infusiones. Sin embargo, existe asistencia financiera disponible para ayudar a reducir los gastos de bolsillo.<\/p>\n\n\n\n<p>El seguro suele cubrir una parte del tratamiento con IgIV para la dermatomiositis si el m\u00e9dico lo considera necesario. Su aseguradora tambi\u00e9n podr\u00eda cubrir el coste de las visitas de infusi\u00f3n domiciliaria para su tratamiento.<\/p>\n\n\n\n<p>Tambi\u00e9n hay varios <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">asistencia para copagos<\/a> programas para ayudar a personas en su situaci\u00f3n a pagar los costos de su tratamiento.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-receive-ivig-therapy-for-dermatomyositis-from-ameripharma-specialty-pharmacy\"><span class=\"ez-toc-section\" id=\"Receive_IVIG_Therapy_for_Dermatomyositis_from_AmeriPharma%C2%AE_Specialty_Pharmacy\"><\/span>Reciba terapia con IgIV para la dermatomiositis en la farmacia especializada AmeriPharma\u00ae<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La dermatomiositis es una enfermedad miop\u00e1tica poco com\u00fan que puede dificultar la vida. Si bien no tiene cura, puede controlar eficazmente sus s\u00edntomas con un tratamiento con IgIV. En la Farmacia Especializada AmeriPharma\u00ae, ofrecemos infusiones de IgIV para ayudarle a vivir mejor.<\/p>\n\n\n\n<p>Con nuestra coordinaci\u00f3n de servicio completo, tendr\u00e1 soporte las 24 horas, los 7 d\u00edas de la semana, los 365 d\u00edas del a\u00f1o, asistencia para la aprobaci\u00f3n del seguro, atenci\u00f3n en el hogar y m\u00e1s.<\/p>\n\n\n\n<p>Podemos entregar medicamentos de IgIV para la dermatomiositis a m\u00e1s de 40 estados y territorios de EE. UU. con entrega discreta al d\u00eda siguiente. Tambi\u00e9n podemos enviar enfermeras certificadas a su domicilio para ayudarle a administrar los tratamientos.<\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/get-started\/\">Empezar<\/a> Visite hoy mismo nuestra farmacia especializada acreditada por URAC y reciba tratamiento con IgIV en casa para la dermatomiositis. Visite nuestra <a href=\"https:\/\/ameripharmaspecialty.com\/es\/blog\/\">blog<\/a> para aprender m\u00e1s sobre las infusiones de IgIV y otros tratamientos para <a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/\">condiciones de salud complejas<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>La dermatomiositis es una enfermedad autoinmune poco com\u00fan que puede afectar tanto a ni\u00f1os como a adultos. A\u00fan no existe cura para la dermatomiositis. Sin embargo, puede evitar sus consecuencias debilitantes mediante tratamiento. Una terapia eficaz para la dermatomiositis es la inmunoglobulina intravenosa (IVIG).<\/p>","protected":false},"author":25,"featured_media":23078,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[31],"class_list":["post-23077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-mark-alfonso"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exploring IVIG for Dermatomyositis | AmeriPharma\u2122 Specialty<\/title>\n<meta name=\"description\" content=\"Are you considering IVIG therapy for dermatomyositis? Learn everything you need to know about IVIG treatment in this guide from AmeriPharma\u2122 Specialty.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exploring IVIG for Dermatomyositis | AmeriPharma\u2122 Specialty\" \/>\n<meta property=\"og:description\" content=\"Are you considering IVIG therapy for dermatomyositis? Learn everything you need to know about IVIG treatment in this guide from AmeriPharma\u2122 Specialty.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-17T20:00:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-12T16:14:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"Exploring IVIG Therapy for Dermatomyositis\",\"datePublished\":\"2023-07-17T20:00:34+00:00\",\"dateModified\":\"2025-05-12T16:14:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/\"},\"wordCount\":1483,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Dermatomyositis-rashes-IVIG.jpg\",\"keywords\":[\"Dr. Mark Alfonso\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/\",\"name\":\"Exploring IVIG for Dermatomyositis | AmeriPharma\u2122 Specialty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Dermatomyositis-rashes-IVIG.jpg\",\"datePublished\":\"2023-07-17T20:00:34+00:00\",\"dateModified\":\"2025-05-12T16:14:55+00:00\",\"description\":\"Are you considering IVIG therapy for dermatomyositis? Learn everything you need to know about IVIG treatment in this guide from AmeriPharma\u2122 Specialty.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Dermatomyositis-rashes-IVIG.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Dermatomyositis-rashes-IVIG.jpg\",\"width\":1280,\"height\":960,\"caption\":\"Dermatomyositis skin rashes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/exploring-ivig-therapy-for-dermatomyositis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exploring IVIG Therapy for Dermatomyositis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Explorando la IgIV para la dermatomiositis | Especialidad AmeriPharma\u2122","description":"\u00bfEst\u00e1 considerando la terapia con IgIV para la dermatomiositis? Aprenda todo lo que necesita saber sobre el tratamiento con IgIV en esta gu\u00eda de AmeriPharma\u2122 Specialty.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/","og_locale":"es_MX","og_type":"article","og_title":"Exploring IVIG for Dermatomyositis | AmeriPharma\u2122 Specialty","og_description":"Are you considering IVIG therapy for dermatomyositis? Learn everything you need to know about IVIG treatment in this guide from AmeriPharma\u2122 Specialty.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-07-17T20:00:34+00:00","article_modified_time":"2025-05-12T16:14:55+00:00","og_image":[{"width":1280,"height":960,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"Exploring IVIG Therapy for Dermatomyositis","datePublished":"2023-07-17T20:00:34+00:00","dateModified":"2025-05-12T16:14:55+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/"},"wordCount":1483,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg","keywords":["Dr. Mark Alfonso"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/","url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/","name":"Explorando la IgIV para la dermatomiositis | Especialidad AmeriPharma\u2122","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg","datePublished":"2023-07-17T20:00:34+00:00","dateModified":"2025-05-12T16:14:55+00:00","description":"\u00bfEst\u00e1 considerando la terapia con IgIV para la dermatomiositis? Aprenda todo lo que necesita saber sobre el tratamiento con IgIV en esta gu\u00eda de AmeriPharma\u2122 Specialty.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg","width":1280,"height":960,"caption":"Dermatomyositis skin rashes"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-therapy-for-dermatomyositis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"Exploring IVIG Therapy for Dermatomyositis"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#website","url":"https:\/\/ameripharmaspecialty.com\/zh\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/zh\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Dr. Mark Alfonso, PharmD, BCMTMS","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"El Dr. Mark Alfonso, doctor en farmacia, naci\u00f3 y creci\u00f3 en Pueblo, Colorado. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Colorado, en el Campus M\u00e9dico Anschutz, en 2010. Obtuvo su certificaci\u00f3n en gesti\u00f3n de terapias farmacol\u00f3gicas en 2022. Lo m\u00e1s gratificante de su trabajo es ayudar a responder las preguntas e inquietudes de los pacientes. Sus \u00e1reas de especializaci\u00f3n son la farmacia comunitaria y la gesti\u00f3n de terapias farmacol\u00f3gicas. En su tiempo libre, disfruta de la lectura y correr.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-300x225.jpg",300,225,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-768x576.jpg",768,576,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-1024x768.jpg",1024,768,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",16,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",600,450,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-86x65.jpg",86,65,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-167x125.jpg",167,125,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-280x210.jpg",280,210,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-370x278.jpg",370,278,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-960x720.jpg",960,720,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Dermatomyositis is a rare autoimmune disease that can affect children and adults alike. There is no cure for dermatomyositis yet. However, you can avoid its debilitating consequences by receiving treatment. One effective therapy for dermatomyositis is IVIG.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-300x225.jpg",300,225,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-1024x768.jpg",1024,768,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",16,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",600,450,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-86x65.jpg",86,65,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-167x125.jpg",167,125,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-280x210.jpg",280,210,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-370x278.jpg",370,278,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG-960x720.jpg",960,720,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/Dermatomyositis-rashes-IVIG.jpg",1280,960,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Dermatomyositis is a rare autoimmune disease that can affect children and adults alike. There is no cure for dermatomyositis yet. However, you can avoid its debilitating consequences by receiving treatment. One effective therapy for dermatomyositis is IVIG.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23077"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23077\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23078"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23077"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}